HussainSAStockenDDPeakeDRet al. Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer. Br J Cancer2004;90(11):2106-11.
2.
PloussardGDaneshmandSEfstathiouJAet al. Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review. Eur Urol2014;66:120-37.
3.
JamesNDHussainSAHallEet al. Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer. N Engl J Med2012;366:1477-88.
4.
KrauseFSWalterBOttOJet al.15-year survival rates after transurethral resection and radiochemotherapy or radiation in bladder cancer treatment. Anticancer Res2011;31:985-90.
5.
CoxJDStetzJPajakTF.Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys1995;31:1341-6.
6.
TrottiAColevasDSetserAet al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol2003;13:176-81.
7.
RubinPConstineLS3rdFajardoLFPhillipsTLWassermanTH. EORTC Late Effects Working Group. Overview of late effects normal tissues. (LENT) scoring system. Radiother Oncol1995;35:9-10.
8.
PerezCAGrigsbyPWLockettMAChaoKSWilliamsonJ.Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation. Int J Radiat Oncol Biol Phys1999; 44: 855-66.
9.
MillerARMartensonJANelsonHet al. The incidence and clinical consequences of treatment-related bowel injury. Int J Radiat Oncol Biol Phys1999; 43: 817-25.
10.
KeysHMBundyBNStehmanFBet al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med1999; 340: 1154-61.
11.
ClassenJBelkaCPaulsenFBudachWHoffmannWBambergM.Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol1998; 174 (Suppl 3): 82-4.
12.
Hauer-JensenMWangJBoermaMFuQDenhamJW.Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management. Curr Opin Support Palliat Care2007; 1: 23-9.
13.
YeohEHorowitzMRussoAet al. Effect of pelvic irradiation on gastrointestinal function: a prospective longitudinal study. Am J Med1993; 95: 397-406.
14.
BirgissonHPåhlmanLGunnarssonUGlimeliusB.Late adverse effects of radiation therapy for rectal cancer – a systematic overview. Acta Oncol2007; 46: 504-16.
15.
EfstathiouJABaeKShipleyWUet al. Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89-03, 95-06, 97-06, 99-06. J Clin Oncol2009;27:4055-61.
16.
HensonC.Chronic radiation proctitis: issues surrounding delayed bowel dysfunction post-pelvic radiotherapy and an update on medical treatment. Therap Adv Gastroenterol2010;3(6):359-65.
17.
FiorinoCValdagniRRancatiTSanguinetiG.Dose-volume effects for normal tissues in external radiotherapy: Pelvis. Radiother Oncol2009; 93:153-67.
18.
O’BrienPCFranklinCIPoulsenMGJosephDJSpryNSDenhamJW. Acute symptoms, not rectally administered sucralfate, predict for late radiation proctitis: longer term follow-up of a phase III trial- Trans-Tasman Radiation Oncology Group. Int J Radiat Oncol Biol Phys2002;54:442-9.
19.
McElvannaKIWilsonAIrwinT.Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis. Colorectal Dis2014;16(4):281-4.
20.
HansonBMacDonaldRShaukatA.Endoscopic and medical therapy for chronic radiation proctopathy: a systematic review. Dis Colon Rectum2012;55:1081-95.
21.
TsujinakaSBaigMKGornevRet al. Formalin instillation for hemorrhagic radiation proctitis. Surg Innov2005;12:123-8.
22.
FeldmeierJJHampsonNB.A systematic review of the literature reporting the application of hyperbaric oxygen prevention and treatment of delayed radiation injuries: an evidence based approach. Undersea Hyperb Med2002;29:4-30.
23.
LibermanDMehusBElliottSP.Urinary adverse effects of pelvic radiotherapy. Transl Androl Urol2014; 3:186-95.
24.
MajewskiWTarnawskiR. Acute and late toxicity in radical radiotherapy for bladder cancer. Clin oncol (R Coll Radiol)2009;21(8):598-609.
25.
KogaFKiharaK.Selective bladder preservation with curative intent for muscle-invasive bladder cancer: a contemporary review. Int J Urol2012; 19(5):388-401.
26.
FokdalLHøyerMMeldgaardPvon der MaaseH. Long-term bladder, colorectal, and sexual functions after radical radiotherapy for urinary bladder cancer. Radiother Oncol2004; 72(2):139-45.
27.
EfstathiouJASpiegelDYShipleyWUet al. Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience. Eur Urol. 2012Apr; 61(4):705-11.
28.
RödelCGrabenbauerGGKuhnRet al. Combined-modality treatment and selective organ preservation in invasive bladder cancer: long-term results. J Clin Oncol2002;20:3061-71.
29.
HamiltonKBennettNCPurdieGet al. Standardized cranberry capsules for radiation cystitis in prostate cancer patients in New Zealand: a randomized double blinded, placebo controlled pilot study. Support Care Cancer. 2015; 23(1):95-102.
